Tradestie Institutional Equity Comparison Engine

ICUI vs LIVN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

LIVN Overall Edge

LIVN Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to LivaNova PLC Ordinary Shares (LIVN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while ICUI counters with relative strength in Valuation. Fundamentally, ICUI trades at 18.2x Forward P/E with 6.7% operating margin (+4.4% YoY revenue) versus LIVN at 19.5x Forward P/E and 14.3% operating margin (+9.9% YoY). In options structure, ICUI sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro) against LIVN sits in CONSOLIDATION (11th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ICUI
ICUI 18.2x vs LIVN 19.5x Fwd P/E
Growth & Margin Winner LIVN
Op Margin 6.7% vs 14.3% ยท YoY +4.4% vs +9.9%
Momentum & Technical Winner LIVN
1Y +31.1% vs +70.8% ยท 52W Pos 78% vs 84%
Options & Structure Winner LIVN
UNCLASSIFIED (2nd %ile IV) vs CONSOLIDATION (11th %ile IV)
ICUI NASDAQ
ICU Medical Inc
Surgical & Medical Instruments & Apparatus
$175.76
-1.52% 1D
Market Cap $4.5B
1M Return +9.28%
1Y Return +31.13%
Forward P/E 18.2x
Unified AI Score
41.4 / 100 SELL
Tech 23.0 Fund 35.0 Flow 50.0 Mom 40.0
LIVN NASDAQ
LivaNova PLC Ordinary Shares
Electromedical & Electrotherapeutic Apparatus
$92.07
-2.61% 1D
Market Cap $5.1B
1M Return +17.38%
1Y Return +70.85%
Forward P/E 19.5x
Unified AI Score
38.5 / 100 SELL
Tech 23.0 Fund 40.0 Flow 70.0 Mom 21.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ICUI +31.13% LIVN +70.85% Spread: +39.72 pp (LIVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ICUI TTM Op. Margin: 6.7% LIVN TTM Op. Margin: 14.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ICUI vs LIVN. Trailing 12-month operating profitability (ICUI 6.7% vs LIVN 14.3%) and valuation multiples (ICUI 18.2x vs LIVN 19.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ICUI (3) vs LIVN (7)
Institutional Metric ICUI LIVN Criterion Row Winner
Market Capitalization Scale $4.5B $5.1B Larger Scale LIVN
Trailing P/E Ratio Valuation 74.7x 26.5x Lower Multiple LIVN
Forward P/E Ratio Valuation 18.2x 19.5x Lower Multiple ICUI
Revenue Growth (YoY) Growth +4.4% +9.9% Higher Growth LIVN
Operating Margin (TTM) Profitability 6.7% 14.3% Higher Margin LIVN
Net Profit Margin Profitability 2.8% 13.0% Higher Margin LIVN
Return on Equity (ROE) Capital Efficiency 2.8% 15.5% Higher ROE LIVN
52-Week Range Position Momentum 78% ($113โ€“$193) 84% ($52โ€“$99) Stronger Trend LIVN
Beta / 30D Volatility Risk Regime 0.89ฮฒ ยท 40% Vol 0.98ฮฒ ยท 67% Vol Lower Realized Risk ICUI
Unified Institutional Score Composite Signal 41.4 / 100 (SELL) 38.5 / 100 (SELL) Higher Composite ICUI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ICUI vs LIVN Buy Guide
ICUI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live ICUI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LIVN CONSOLIDATION
97d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live LIVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ICUI nor LIVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.